Zhejiang Medicine Company Reduces Batch Review Cycle Time 46-75% with PharmaSuite MES
Zhejiang Medicine Company implemented a Safety & Compliance Monitoring project in Pharmaceuticals. As reported by rockwellautomation.com: 46-75% batch review cycle time reduction.
Source-reported figures (cited source: rockwellautomation.com)
What Zhejiang Medicine Company was trying to fix
Zhejiang Medicine Company's new Novus Pharmaceuticals subsidiary needed to transition to a completely paperless environment to meet FDA compliance requirements for its new antibiotic manufacturing facility serving U.S. and European regulated markets.
What Zhejiang Medicine Company deployed
ZMC implemented FactoryTalk PharmaSuite MES, which integrated production processes from the plant floor to the enterprise, with electronic batch records (EBR) digitizing paper records and automating document management for FDA 21 CFR Part 11 compliance.
Results
ZMC completely eliminated paper-based SOPs, hardcopy records, and equipment/material labels. Labor costs were reduced by 5-10%. Batch product review cycle time was reduced by 46-75%, and management-review cycle time was reduced by 50%.
Key Takeaways
- At ZMC, electronic batch records cut batch review cycle time by 46-75% compared with paper-based batch documentation
- Paperless MES implementation reduced labor costs 5-10% and improved data integrity and regulatory compliance
- Chinese pharmaceutical manufacturers targeting FDA-regulated markets must implement 21 CFR Part 11 compliant EBR systems as a prerequisite for product approval
Evidence for Zhejiang Medicine Company's Safety & Compliance Monitoring deployment
- Reported outcome metrics
- 3 cited below
- Cited source
- rockwellautomation.com
- Last updated
Vendor
Details
- Industry
- Pharmaceuticals
- Use Case
- Safety & Compliance Monitoring
- AI Technology
- Not available in record
- Company Size
- Enterprise
- Company
- Zhejiang Medicine Company
Have a similar implementation?
Share your customer's AI results and link it to your vendor profile.
Submit a case study →